-
Analyst: Don't Expect Anika's Latest FDA Cleared Treatment To Impact 2018
Thursday, December 28, 2017 - 12:38pm | 340Anika Therapeutics Inc (NASDAQ: ANIK) announced Wednesday it has received clearance from the U.S. Food and Drug Administration for its HA-based bone void filler, which is used to fill bone voids or defects of the skeletal system. The Analyst Barrington Research's Michael Petusky maintains an...
-
Highlights From Carvana's In-Line Q3
Wednesday, November 8, 2017 - 1:43pm | 418Carvana Co (NYSE: CVNA) reported second-quarter earnings Tuesday that showed a slightly better-than-expected loss of 29 cents per share versus expectations of a 30 cent per share loss on on worse-than-expected revenue. Carvana confirmed it has secured $2 billion in financing from Ally...
-
IMAX Building Optimistic Anticipation
Friday, February 24, 2017 - 12:28pm | 385IMAX Corporation (USA) (NYSE: IMAX) reported its fourth-quarter results ahead of the conservative expectations, with revenues significantly beating the estimate, although declining year-on-year. Barrington’s James C. Goss maintains an Outperform rating on the company, with a price target of $...
-
Pandora's Bounce Back Doesn't Win Over Barrington Analysts
Tuesday, January 3, 2017 - 5:17pm | 224Pandora Media Inc (NYSE: P) recently said it was working on new revenue generation opportunities, although these would bring added costs. Having said this, some of its new services might help it reduce churn, while opening new monetization paths. However, in a recent report, Barrington Research...
-
The Premium AT&T Offered To Time Warner Shareholders Should Sustain Itself Through The Regulatory Process
Monday, October 24, 2016 - 1:35pm | 490AT&T Inc. (NYSE: T)'s takeover of Time Warner Inc (NYSE: TWX) should face increased regulatory scrutiny. However, Barrington Research said AT&T’s premium to Time Warner shareholders “seems appropriate to sustain itself even within the context of a potentially lengthy regulatory...
-
Barrington Maintains Outperform Rating On Healthways Ahead Of Q3 Earnings
Thursday, October 13, 2016 - 11:03am | 347Barrington Research maintains an Outperform rating on Healthways, Inc. (NASDAQ: HWAY) ahead of its third-quarter results on November 1 and following the closure of the unprofitable total population health solutions business. The brokerage expects adjusted EPS of $0.52 while the consensus estimate...
-
Cogint's Shares Come Under Pressure, But Its Fundamentals Remain Positive
Thursday, October 13, 2016 - 10:31am | 381Although Cogint, Inc. (NASDAQ: COGT) shares have come under meaningful pressure, declining 35 percent from its recent highs following the up-listing of the stock to NASDAQ, Barrington’s James C. Goss believes the “fundamental story continues to be positive.” Goss maintains an...
-
A Preview Of ExlService's Q3 Earnings
Thursday, October 13, 2016 - 10:17am | 368Barrington Research expects ExlService Holdings, Inc. (NASDAQ: EXLS) earnings and revenues lower than consensus, when it reports its third-quarter financial results on October 27, despite maintaining an Outperform rating on the stock. Analyst Vincent Colicchio anticipates third quarter non-GAAP EPS...
-
Barrington Upgrades DeVry On Positive Expectations For Management Execution
Wednesday, September 14, 2016 - 9:46am | 373Barrington Research has upgraded DeVry Education Group Inc (NYSE: DV) to Outperform, saying the company is at an inflection point and adjusted operating income's continued growth is likely. The brokerage, which set a price target of $30, sees a potential opportunity for DeVry from the abrupt...
-
Barrington Initiates Superior Uniform Group At Outperform, Expects Organic Growth To Remain Strong
Tuesday, August 30, 2016 - 8:53am | 417Barrington Research has started coverage of Superior Uniform Group Inc (NASDAQ: SGC) with an Outperform rating and $21 price target, as it sees substantial opportunity for continued solid organic sales growth driven by market share gains and margin expansion from expense leverage. The brokerage...
-
Bottomline Tech's Transition Of Legacy Customers To Digital Banking Platform Creating Near-Term Headwinds
Monday, August 22, 2016 - 11:11am | 226Barrington Research previewed Bottomline Technologies (NASDAQ: EPAY) Q4 results in a note published Monday. The analysts expect the Q4 revenue and core EPS to come at $86 million (versus a consensus of $87 million) and $0.30 (same as the consensus), respectively. They believe Q4 2016 will...
-
Barrington Research Previews Zebra Technologies Q2 Earnings
Monday, August 8, 2016 - 4:47pm | 340Barrington Research expects Zebra Technologies Corp. (NASDAQ: ZBRA)' earnings and revenues for the second quarter below consensus. Zebra Technologies, which makes enterprise mobile computers and advanced data capture devices, will report the financial results for its second quarter on August 9,...
-
Upcoming Non-Deal Road Shows For Syntel, Franklin Covey And Others
Tuesday, July 12, 2016 - 2:16pm | 404Get ready for a series of non-deal road shows. A non-deal road show occurs where executives hold talks with current and potential investors, but nothing is offered for sale. Barrington Research put up a list of upcoming non-deal road shows: July 14, 2016: Lawson Products, Inc. (NASDAQ: LAWS) in...
-
Barrington Sees K12 Q4 EPS To Drop 33.3%
Tuesday, July 12, 2016 - 1:57pm | 373Barrington Research expects a 33.3 percent drop in K12 Inc. (NYSE: LRN)'s fourth-quarter EPS despite being positive on its settlement with the CAG. Analyst Alexander Paris projects the fourth-quarter EPS of the technology-based education company at $0.12, down 33.3 percent from $0.18 last year....
-
Barrington Initiates IDI Inc. With An Outperform Rating
Tuesday, July 12, 2016 - 10:12am | 242While risk management is the current priority for IDI, Inc. (NYSE: IDI), the company ultimately targets custom big data and analytics, Barrington Research’s James C. Goss said in a report. He initiated coverage of the company with an Outperform rating and a price target of $7. While the...